Aortic Prosthesis-Associated MDR Pseudomonas Infections as a Diagnostic and Therapeutic Challenge

Rita Filipe; Filipa Ceia; Ana Cláudia Carvalho; Margarida Tavares; José Teixeira; António Sarmento

doi:10.3390/idr12030012

Aortic Prosthesis-Associated MDR Pseudomonas Infections as a Diagnostic and Therapeutic Challenge

Infect Dis Rep. 2020 Nov 2;12(3):46-50. doi: 10.3390/idr12030012.

Authors

Rita Filipe^{1

2}, Filipa Ceia^{1

2}, Ana Cláudia Carvalho¹, Margarida Tavares^{1

3}, José Teixeira⁴, António Sarmento^{1

2}

Affiliations

¹ Infectious Diseases Department, São João University Hospital Center, 4000-319 Porto, Portugal.
² Faculty of Medicine, University of Porto, 4000-319 Porto, Portugal.
³ EPI Unit, Public Health Institute of Porto University, 4000-319 Porto, Portugal.
⁴ Vascular Surgery Department, São João University Hospital Center, 4000-319 Porto, Portugal.

Abstract

Endovascular prostheses are used to treat life-threatening conditions such as ruptured aortic aneurysms. Prosthetic infection cause significant morbidity and mortality, posing important diagnostic and therapeutic challenges. It is particularly difficult to diagnose and, in the era of multidrug resistance (MDR), these type of infections may become even more difficult to treat. Herein, we reported a case of a secondary prosthetic endovascular infection following repeated bacteremia episodes from a urinary source. This case illustrates an MDR Pseudomonas aeruginosa aortic infection that was difficult to diagnose with no oral antibiotic treatment options.

Keywords: MDR Pseudomonas; PET scan; aortic prosthesis infection; axilobifemoral revascularization.

Publication types

Case Reports